- Home
- Research
- Inflammation
- pH-responsive and self-adaptive hydrogel dressing based on a TA/PVA network co-loaded with cannabidiol and mupirocin for synergistic infected wound healing.
Smart CBD wound dressing adapts to heal infected wounds faster
pH-responsive and self-adaptive hydrogel dressing based on a TA/PVA network co-loaded with cannabidiol and mupirocin for synergistic infected wound healing.
AI Summary
This study developed an innovative smart hydrogel wound dressing that combines cannabidiol (CBD) with the antibiotic mupirocin to treat infected and chronic wounds. The hydrogel is made from tannic acid and polyvinyl alcohol using an environmentally friendly process, creating a porous material that intelligently responds to different pH levels in the wound microenvironment. Under acidic conditions (typical of infected wounds), the dressing releases drugs slowly for sustained healing, while in alkaline conditions, it accelerates drug release—essentially adapting its therapeutic action based on the specific wound environment.
In laboratory testing, the hydrogel demonstrated potent antibacterial activity against multiple bacteria species, strong antioxidant effects, and excellent safety for human cells. The material successfully promoted fibroblast migration, a critical process for new tissue formation. When tested in living mice with full-thickness wounds, the hydrogel achieved 72.8% wound closure by day 7 and significantly improved tissue regeneration through enhanced re-epithelialization, collagen deposition, and blood vessel formation. All safety assessments confirmed the dressing posed no harm to surrounding tissues.
This research exemplifies how CBD and other cannabinoids can be integrated into advanced therapeutic delivery systems for clinical applications beyond traditional smoking or oral consumption. The synergistic combination of CBD's anti-inflammatory and antioxidant properties with conventional antibiotics represents a novel approach to managing difficult-to-treat wounds, offering practical benefits for patients with infected or chronic wounds who may not respond well to standard treatments."
📄
Original Abstract
Related Research
Similar Studies
More Inflammation research papers you might find interesting.
A small evidence base leaves cannabinoid effects on RA pain uncertain
Targeted CB2 drug delivery reduced mouse plaque deposits, with sex differences
Review finds promise in acidic cannabinoids, but human benefits remain unproven
Explore More Research
Stay informed about the latest cannabis science.